Cargando…

Impact of Antibodies That React With Liver Tissue and Donor-Specific Anti-HLA Antibodies in Pediatric Idiopathic Posttransplantation Hepatitis

BACKGROUND: The cause of late graft dysfunction has not been elucidated. Although an antibody-mediated reaction is suspected as a potential mechanism, the target antigens have not been clarified. METHODS: To clarify the etiology of idiopathic posttransplantation hepatitis (IPTH), we simultaneously e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hirata, Yoshihiro, Yoshizawa, Atsushi, Egawa, Hiroto, Ueda, Daisuke, Okamoto, Shinya, Okajima, Hideaki, Yurugi, Kimiko, Hishida, Rie, Hirai, Hideyo, Miyagawa-Hayashino, Aya, Maekawa, Taira, Haga, Hironori, Uemoto, Sinji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Original Clinical Science—Liver
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642348/ https://www.ncbi.nlm.nih.gov/pubmed/28118175 http://dx.doi.org/10.1097/TP.0000000000001653

Ejemplares similares

Significance of Semiquantitative Assessment of Preformed Donor-Specific Antibody Using Luminex Single Bead Assay in Living Related Liver Transplantation
por: Yoshizawa, Atsushi, et al.
Publicado: (2013)

Low Titers of Antidonor ABO Antibodies After ABO-Incompatible Living Donor Liver Transplantation: A Long-Term Follow-Up Study
por: Ueda, Daisuke, et al.
Publicado: (2018)

Posttransplantation lymphoproliferative disorder involving liver after renal transplantation
por: Shin, Yong Moon
Publicado: (2011)

Bortezomib Against Refractory Antibody-Mediated Rejection After ABO-Incompatible Living-Donor Liver Transplantation: Dramatic Effect in Acute-Phase?
por: Tajima, Tetsuya, et al.
Publicado: (2019)

Long-term Prognosis and Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A Single-Center Experience
por: Ueda, Yoshihide, et al.
Publicado: (2017)

Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey
por: Akamatsu, Nobuhisa, et al.
Publicado: (2021)

Rituximab Induction to Prevent the Recurrence of PSC After Liver Transplantation—The Lessons Learned From ABO-Incompatible Living Donor Liver Transplantation
por: Yamada, Yohei, et al.
Publicado: (2018)

The impact of human leukocyte antigen mismatch on recipient outcomes in living‐donor liver transplantation
por: Tajima, Tetsuya, et al.
Publicado: (2022)

Acute Antibody-mediated Rejection Coexisting With T Cell–mediated Rejection in Pediatric ABO-incompatible Transplantation
por: Yanagi, Yusuke, et al.
Publicado: (2022)

Outcomes of Living Donor Liver Transplantation Alone for Patients on Maintenance Renal Replacement Therapy in Japan: Results of a Nationwide Survey
por: Eguchi, Susumu, et al.
Publicado: (2016)

A Rare Case of Adult Autoimmune Neutropenia Successfully Treated with Prednisolone
por: Fujita, Mari, et al.
Publicado: (2017)

Antibody-mediated rejection after adult living-donor liver transplantation triggered by positive lymphocyte cross-match combination
por: Hori, Tomohide, et al.
Publicado: (2012)

Belatacept Treatment of Recurrent Late-onset T Cell–mediated Rejection/Antibody-mediated Rejection With De Novo Donor-specific Antibodies in a Liver Transplant Patient
por: Klintmalm, Göran B., et al.
Publicado: (2022)

Impact of the Trough Level of Calcineurin Inhibitor on the Prevalence of Donor-Specific Human Leukocyte Antigen Antibodies During Long-Term Follow-Up After Pediatric Liver Transplantation: Antibody Strength and Complement-Binding Ability
por: Tokodai, Kazuaki, et al.
Publicado: (2017)

The Impact of Biliary Reconstruction Methods on Small Partial Liver Grafts
por: Yoshikawa, Junichi, et al.
Publicado: (2020)

ABO-incompatible Pediatric Liver Transplantation With Antibody and B-cell Depletion-free Immunosuppressive Protocol in High Consanguinity Communities
por: Shagrani, Mohammad, et al.
Publicado: (2022)

Donor-specific Antibodies, Immunoglobulin-free Light Chains, and BAFF Levels in Relation to Risk of Late-onset PTLD in Liver Recipients
por: Engels, Eric A., et al.
Publicado: (2018)

Pretransplant Serum Hepatitis C Virus RNA Levels Predict Response to Antiviral Treatment after Living Donor Liver Transplantation
por: Ueda, Yoshihide, et al.
Publicado: (2013)

Correction: Pretransplant Serum Hepatitis C Virus RNA Levels Predict Response to Antiviral Treatment after Living Donor Liver Transplantation
por: Ueda, Yoshihide, et al.
Publicado: (2013)

Posttransplantation Lymphoproliferative Disease Treated by Retransplantation
por: Weum Abrahamsen, Ingerid, et al.
Publicado: (2020)

Longitudinal Analysis of the Intestinal Microbiota in Liver Transplantation
por: Kato, Karin, et al.
Publicado: (2017)

Understanding renal posttransplantation anemia in the pediatric population
por: Galutira, Paul Joseph, et al.
Publicado: (2011)

Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors
por: Shiina, Shuichiro, et al.
Publicado: (2012)

CXCR4 Expression Predicts Early Liver Recurrence and Poor Survival After Resection of Pancreatic Adenocarcinoma
por: Liao, Wei-Chih, et al.
Publicado: (2012)

Salford alcohol assertive outreach team: a new model for reducing alcohol-related admissions
por: Hughes, Neill R, et al.
Publicado: (2013)

Acute kidney injury is independently associated with death in patients with cirrhosis
por: Scott, Robert A, et al.
Publicado: (2013)

The Royal Free Hospital Score: A Calibrated Prognostic Model for Patients With Cirrhosis Admitted to Intensive Care Unit. Comparison With Current Models and CLIF-SOFA Score
por: Theocharidou, Eleni, et al.
Publicado: (2014)

Low Levels of 25-Hydroxy Vitamin D are Independently Associated with the Risk of Bacterial Infection in Cirrhotic Patients
por: Anty, Rodolphe, et al.
Publicado: (2014)

Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
por: Dyson, Jessica K, et al.
Publicado: (2014)

Non-alcoholic fatty liver disease: a practical approach to treatment
por: Dyson, J K, et al.
Publicado: (2014)

CT With Hepatic Arterioportography as a Pretreatment Examination for Hepatocellular Carcinoma Patients: A Randomized Controlled Trial
por: Ohki, Takamasa, et al.
Publicado: (2013)

Analysis of Notch and TGF-β Signaling Expression in Different Stages of Disease Progression During Hepatitis B Virus Infection
por: Trehanpati, Nirupama, et al.
Publicado: (2012)

Hepatitis B in pregnancy
por: Dyson, Jessica Katharine, et al.
Publicado: (2014)

Network and satellite arrangements in liver disease
por: O'Grady, John G
Publicado: (2013)

Response to the NCEPOD report: development of a care bundle for patients admitted with decompensated cirrhosis—the first 24 h
por: McPherson, Stuart, et al.
Publicado: (2016)

Non-alcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behaviour and lower levels of physical activity than matched healthy controls
por: Hallsworth, Kate, et al.
Publicado: (2015)

Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing Agents
por: Shiffman, Mitchell L, et al.
Publicado: (2016)

A Tissue-Based Comparative Effectiveness Analysis of Biomarkers for Early Detection of Colorectal Tumors
por: Ahmed, Deeqa, et al.
Publicado: (2012)

A Comprehensive Analysis of Common Genetic Variation Around Six Candidate Loci for Intrahepatic Cholestasis of Pregnancy
por: Dixon, Peter H, et al.
Publicado: (2014)

Non-invasive markers of liver fibrosis in fatty liver disease are unreliable in people of South Asian descent
por: De Silva, Sampath, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_712brm9le68h864aupfdpu41lo